Table 1

Weighted age-specific seroprevalences for HPV6, -11, -16 and -18 among 11–26-year-old females, The Netherlands, 2007

Age (years)NProportion seropositive (%), 95% CI
HPV6*HPV11HPV6/11HPV16HPV18HPV16/18HPV6/11/16/18
Overall6373.92.1 to 5.61.20.1 to 2.44.32.5 to 6.13.92.0 to 5.91.10.3 to 1.94.42.4 to 6.47.95.0 to 10.7
11–12890.00.0 to 3.50.00.0 to 4.50.00.0 to 3.10.00.0 to 3.10.00.0 to 3.10.00.0 to 3.10.00.0 to 3.1
13–14750.00.0 to 4.42.20.0 to 6.61.70.0 to 5.20.00.0 to 3.90.00.0 to 4.00.00.0 to 3.91.70.0 to 5.2
15–16640.00.0 to 4.72.70.0 to 8.02.10.0 to 6.20.00.0 to 4.60.00.0 to 4.60.00.0 to 4.62.10.0 to 6.2
17–18690.00.0 to 4.40.00.0 to 5.10.00.0 to 4.22.80.0 to 6.41.40.0 to 4.22.80.0 to 6.42.80.0 to 6.4
19–20964.00.0 to 8.70.00.0 to 3.93.80.0 to 8.23.20.0 to 7.22.30.0 to 5.53.90.0 to 8.07.01.2 to 12.8
21–227810.72.7 to 18.71.10.0 to 3.710.42.6 to 18.15.90.2 to 11.72.20.0 to 5.47.21.0 to 13.415.77.5 to 23.8
23–24773.70.0 to 7.72.70.0 to 6.55.40.0 to 10.811.71.6 to 21.83.00.0 to 6.413.83.2 to 24.317.97.0 to 28.7
25–268912.43.7 to 21.21.30.0 to 4.011.33.2 to 19.47.92.1 to 13.80.00.0 to 3.17.92.1 to 13.816.07.0 to 25.0
  • * For 41 females, insufficient material was available for the HPV6 test.

  • For 139 females, insufficient material was available for the HPV11 test.

  • For four females, insufficient material was available for the HPV18 test.